Asset sale Announced
Element Biosystems acquisition of Standard BioTools Mass Cytometry business
US$5.5m consideration
Announced 30 Sep 2026
Advisers
Standard BioTools Mass Cytometry business
Target
Not disclosed
Other advisers
- Financial adviser
- DPO&Co
- Target
- Standard BioTools Mass Cytometry business
- Acquirer
- Element Biosystems
- Seller
- Standard BioTools
- Target based in
- United States
- Buyer based in
- United States
- Seller based in
- United States
- Sector
- Life Sciences
- Tags
- Life Sciences, Instrumentation
In the league tables
Similar deals
- Waters acquisition of BD Biosciences & Diagnostic Solutions business Jul 2025 · US$19bn · Life Sciences
- Lafayette Instrument acquisition of Avisoft Bioacoustics Jul 2026 · Life Sciences
- Lafayette Instrument acquisition of Sutter Instrument Corp. May 2026 · Manufacturing
- Azenta UK acquisition of UK Biocentre Mar 2026 · US$26.9m · Life Sciences
- Biotron acquisition of Sedarex Oct 2025 · US$980,700 · Healthcare